These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11563055)

  • 21. Synergistic stabilization of nucleic acid assembly by oligo-N3'-->P5' phosphoramidate modification and additions of comb-type cationic copolymers.
    Torigoe H; Maruyama A
    J Am Chem Soc; 2005 Feb; 127(6):1705-10. PubMed ID: 15701004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of monomers bearing at the 2'-position cyanomethoxycarbonyl group for phosphoramidite oligonucleotide synthesis.
    Vasilyeva SV; Abramova TV; Silnikov VN
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):993-8. PubMed ID: 15560092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological evaluation of phosphoramide derivatives as urease inhibitors.
    Domínguez MJ; Sanmartín C; Font M; Palop JA; San Francisco S; Urrutia O; Houdusse F; García-Mina J
    J Agric Food Chem; 2008 May; 56(10):3721-31. PubMed ID: 18452297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syntheses and spectroscopic characterization of some phosphoramidates as reversible inhibitors of human acetylcholinesterase and determination of their potency.
    Gholivand K; Shariatinia Z; Khajeh K; Naderimanesh H
    J Enzyme Inhib Med Chem; 2006 Feb; 21(1):31-5. PubMed ID: 16570502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein and RNA of human telomerase as targets for modified oligonucleotides.
    von Janta-Lipinski M; Gaertner K; Lehmann C; Scheer H; Schildt J; Matthes E
    Nucleosides Nucleotides; 1999; 18(6-7):1719-20. PubMed ID: 10474255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
    Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
    Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
    Matray TJ; Gryaznov SM
    Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between properties of 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) phosphorothioate oligonucleotides and N3'-P5' thiophosphoramidate oligonucleotides.
    Horie M; Morita K; Kawakami J; Ando O; Koizumi M; Tsutsumi S
    Nucleosides Nucleotides Nucleic Acids; 2006 Mar; 25(3):231-42. PubMed ID: 16629117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Schultz RG; Gryaznov SM
    Nucleic Acids Res; 1996 Aug; 24(15):2966-73. PubMed ID: 8760881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel phosphoramidates with porphine and nitrogenous drug: one-pot synthesis and orientation to cancer cells.
    Wang ZW; Guo CC; Xie WZ; Liu CZ; Xiao CG; Tan Z
    Eur J Med Chem; 2010 Mar; 45(3):890-5. PubMed ID: 19942325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and anticancer activity of some 5-fluoro-2'-deoxyuridine phosphoramidates.
    Lewandowska M; Ruszkowski P; Chojnacka K; Kleczewska N; Hoffmann M; Kacprzak K; Celewicz L
    Bioorg Med Chem; 2016 May; 24(10):2330-41. PubMed ID: 27073055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic stabilization of triplex by combination of comb-type cationic copolymer and oligo-N3'-->P5' phosphoramidates.
    Torigoe H; Akaike T; Maruyama A
    Nucleic Acids Res Suppl; 2001; (1):195-6. PubMed ID: 12836331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zwitterionic oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Mignet N; Gryaznov SM
    Nucleic Acids Res; 1998 Jan; 26(2):431-8. PubMed ID: 9421496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
    Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
    Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S; Skorski T; Cucco C; Nieborowska-Skorska M; Chiu CY; Lloyd D; Chen JK; Koziolkiewicz M; Calabretta B
    Nucleic Acids Res; 1996 Apr; 24(8):1508-14. PubMed ID: 8628685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.
    Dikmen ZG; Gellert GC; Jackson S; Gryaznov S; Tressler R; Dogan P; Wright WE; Shay JW
    Cancer Res; 2005 Sep; 65(17):7866-73. PubMed ID: 16140956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-Acyl-phosphoramidates as potential novel form of gemcitabine prodrugs.
    Baraniak J; Pietkiewicz A; Kaczmarek R; Radzikowska E; Kulik K; Krolewska K; Cieslak M; Krakowiak A; Nawrot B
    Bioorg Med Chem; 2014 Apr; 22(7):2133-40. PubMed ID: 24631359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promotion of triplex formation by N3'-->P5' phosphoramidate modification: thermodynamic and kinetic studies.
    Torigoe H
    Nucleic Acids Res Suppl; 2001; (1):57-8. PubMed ID: 12836262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.